Skip to main content Accessibility help
×
Home

Long–term survival in trial of medium–titre Edmonston–Zagreb measles vaccine in Guinea–Bissau: five–year follow–up

  • P. Aaby (a1), I. M. Lisse (a2), H. Whittle (a3), K. Knudsen (a1), J. Thaarup (a4), A. Poulsen (a4), M. Sodemann (a4), M. Jakobsen (a4), L. Brink (a4), U. Gansted (a4), A. Permin (a4), T. G. Jensen (a4), H. Andersen (a5) and M. C. da Silva (a6)...

Summary

A trial of protective efficacy which compared medium–titre Edmonston-Zagreb (EZ) measles vaccine (104.6 p.f.u.) from the age of 4 months with the standard Schwarz (SW) measles vaccine given from the age of 9 months was started in an urban community in Guinea-Bissau in 1985. Because trials of high–titre measles vaccine have found increased mortality among female recipients, we examined whether EZ medium–titre vaccine was associated with any long-term impact on mortality, suppression of T–cells, or growth. The mortality rate ratio over 5 years of follow–up was 1.12 for EZ children compared with children in the standard group (P = 0.63). Seventy–five percent of the children still residing in the area at 5 years of age took part in an immunological and anthropometric examination. There was no difference in T–cell subsets between the two groups. There was no difference in mid–upper–arm circumference, but EZ children were significantly shorter than the children in the standard group. In conclusion, medium–titre EZ was not associated with reduced survival or persistent immunosuppression.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Long–term survival in trial of medium–titre Edmonston–Zagreb measles vaccine in Guinea–Bissau: five–year follow–up
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Long–term survival in trial of medium–titre Edmonston–Zagreb measles vaccine in Guinea–Bissau: five–year follow–up
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Long–term survival in trial of medium–titre Edmonston–Zagreb measles vaccine in Guinea–Bissau: five–year follow–up
      Available formats
      ×

Copyright

Corresponding author

*Peter Aaby, Epidemiology Research Unit, Artillerivej 5, 2300 Copenhagen S, Denmark.

References

Hide All
Aaby, P, Knudsen, K, Jensen, TG et al. , Measles incidence, vaccine efficacy and mortality in two urban African areas with high vaccination coverage. J Infect Dis 1990; 162: 1043–8.
Aaby, P, Clements, J. Measles immunization research. A review. Bull WHO 1989; 67: 443–8.
Loening, WEK, Coovadia, HM. Age–specific occurrence rates of measles in urban, peri–urban, and rural environments: implications for time of vaccination. Lancet 1983; ii: 324–6.
Dabis, F, Sow, A, Waldman, RJ et al. , The epidemiology of measles in a partially vaccinated population in an African city: implications for immunization programmes. Am J Epidemiol 1988; 127: 171–8.
Whittle, H, Hanlon, P, O'Neill, K et al. , Trial of high–dose Edmonston–Zagreb measles vaccine in The Gambia: antibody response and side-effects. Lancet 1988; ii: 811–14.
Tidjani, O, Grunitsky, B, Guerin, N et al. , Serological effects of Edmonston–Zagreb, Schwarz, and AIK–C measles vaccine strains given at ages 4–5 or 8–10 months. Lancet 1989; ii: 1357–60.
Markowitz, LE, Sepulveda, J, Diaz-Ortega, JL et al. , Immunization of six–month–old infants with different doses of Edmonston–Zagreb and Schwarz measles vaccines. N Engl J Med 1990; 322: 580–7.
Aaby, P, Jensen, TG, Hansen, HL et al. , Trial of high–dose Edmonston–Zagreb measles vaccine in Guinea–Bissau: protective efficacy. Lancet 1988; ii: 809–11.
9.Expanded Programme on Immunization: Global Advisory Group. Weekly Epidem Rec 1990; 65: 511.
Whittle, HC, Campbell, H, Rahman, S, Armstrong, JRM. Antibody persistence in Gambian children after high–dose Edmonston–Zagreb measles vaccine. Lancet 1990; 336: 1046–8.
Aaby, P, Knudsen, K, Whittle, H et al. , Long–term survival after Edmonston–Zagreb measles vaccination: increased female mortality. J Pediatr 1993; 122: 904–8.
Aaby, P, Samb, B, Simondon, Knudsen K et al. , Divergent mortality for male and female recipients of low-titre and high–titre measles vaccines in rural Senegal. Am J Epidemiol 1993; 138: 746–55.
Halsey, N. Increased mortality following high titre measles vaccines: too much of a good thing. J Pediatr Infect Dis 1993: 12: 462–5.
14.Expanded Programme on Immunization. Consultation on studies involving high titre measles vaccines. Weekly Epidemiol Rec 1992; 67: 357–61.
Whittle, HC, Mann, G, Eccles, M et al. , Effects of dose and strain of vaccine on success of measles vaccination of infants aged 4–5 months. Lancet 1988; 1: 963–6.
Hall, A, Aaby, P. Tropical trials and tribulations. Int J Epidemiol 1990; 19: 777–81.
Lisse, IM, Whittle, H, Aaby, P, Normark, M, Gyhrs, A, Ryder, LP. Labelling of T–cell subsets under field conditions in tropical countries. Adaptation of the immuno–alkaline phosphatase staining method for blood–smears. J Immunol Methods 1990; 129: 4953.
Cox, DR, Oakes, D. Analysis of survival data. London: Chapman and Hall, 1984.
Aaby, P, Andersen, M, Sodemann, , Jakobsen, M, Gomes, J, Fernandes, M. Reduced childhood mortality following standard measles vaccination at 4–8 months compared to 9–11 months of age. BMJ 1993; 307: 1308–11.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed